Navigation Links
Glenmark's Consolidated Revenue Increases by 16.56% to Rs. 14630.06 Mn for Q2 FY 13-14
Date:10/31/2013

mp; MD - Glenmark.  Although the operating environment continues to remain challenging in emerging markets, we are reasonably confident of continuing on the same growth trajectory."

For the six month ended Sep 30, 2013, Glenmark's consolidated revenue was at Rs. 27008.88 Mn [USD 457.46 Mn] as against Rs. 22955.98 Mn [USD 418.52 Mn], an increase of 17.66 %. Revenue from the generics business was at Rs. 13374.19 Mn (USD 226.52 Mn), as against Rs. 11118.97 Mn (USD 202.71 Mn), a growth of 20.28 %. The Speciality formulation business revenue (excluding out-licensing revenue) was Rs. 13516.59. Mn (USD 228.93 Mn) as against Rs. 11837.01 (USD  215.80 Mn) for the corresponding previous six month period, recording a growth of 14.19%.

Specialty Business:

Sales for the formulation business in India for the second quarter ended Sep 30, 2013, was at Rs. 4176.80 Mn [USD 67.51Mn] as against Rs. 3440.27 Mn [USD 62.47 Mn] in the previous corresponding quarter, recording a growth of 21.41% For the second quarter, revenue from Africa, Asia and CIS region was as against Rs.1735.91Mn [USD 27.74Mn] as against Rs. 1941.00 Mn [USD 35.26 Mn] for the previous corresponding quarter. Glenmark's revenue from its Latin American and Caribbean operations was at Rs. 966.00Mn [USD 15.50Mn] for the second quarter ended Sep 30, 2013 as against Rs. 990.54Mn [USD 18.00Mn] for the previous corresponding period.

Generics Business:

Glenmark Generics Inc., U.S.A. registered revenue from sale of finished dosage formulations was Rs. 5578.60Mn (USD 90.09Mn) for the quarter ended Sep 30, 2013against revenue of 4307.21 Mn (USD 78.17 Mn) for the previous corresponding quarter, recording an increase of 29.52%. The European business posted revenues of Rs. 517.20 Mn (USD8.30Mn) for the quarter ended Sep 30, 2013against revenue of R
'/>"/>

SOURCE Glenmark Pharmaceuticals Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CryoLife Third Quarter 2013 Revenues Increase 8 Percent to a Record $36.3 Million
2. Neogen reports 18% revenue increase
3. Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL
4. BioLife Solutions Announces Record Revenue of $2.3 Million in the Second Quarter of 2013
5. Sales Momentum Helps Companies Drive Revenue by Getting Major Account Sales Strategy Right
6. BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013
7. SPO Returns to Revenue Generation
8. Global Nano-Materials Market 2002-2016: Nano-Materials Industry, Production Volumes, Revenues and End User Market Demand - MarketResearchReports.Biz
9. Medical Marijuana Inc., Corporate Update- Significant Revenue and Net Income Growth 1st Quarter- Division and Corporate Holdings Update
10. Adeptia Announces 75% Revenue Increase for 2012 Calendar Year
11. Ekahau Achieves 45% Year-over-Year Revenue Growth and Strong Adoption of Safety Alert Solution in 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Wash. , Dec. 24, 2014   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... media and precision thermal shipping products for ... that it will hold its 2015 Annual Meeting of ... Because the expected date for the Annual Meeting ...
(Date:12/24/2014)... 23, 2014 On Friday, December ... 83, the Omnibus and Continuing Resolution Appropriations Act ... hydrocephalus a condition eligible to receive funding through ... by the Department of Defense (DoD). The Hydrocephalus ... on Capitol Hill, is celebrating this victory for ...
(Date:12/24/2014)... December 23, 2014 Pipette.com announces their ... Twitter followers can submit their #HolidayInTheLab pictures for a ... lab mates. , For those struggling to think of ... Pipette.com Holiday in the Lab Contest provides the ideal ... followers to send pictures of their chemistree, holiday ...
(Date:12/24/2014)... , Dec. 23, 2014  Rock Creek Pharmaceuticals, ... it has filed a Clinical Trial Application (CTA) with ... products Regulatory Agency (MHRA) seeking regulatory approval to initiate ... molecule, Anatabine Citrate. Contingent on the Company ... a Phase I trial to assess the safety, tolerability ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... 8 Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) announced ... Bank of America 2008 Healthcare Conference on May 14, ... at the Four Seasons Hotel in Las,Vegas, Nevada. Dominic ... Officer, is scheduled to provide an overview of the,company, ...
... (NYSE: EW ), the world leader in the ... a number of cardiac surgery,milestones and product debuts at ... Surgery (AATS), May 10-14 in San Diego., Among ... celebrates,its 50th anniversary of partnering with clinicians to develop ...
... NEW YORK, May 8 Keryx Biopharmaceuticals,Inc. (Nasdaq: ... May 12, 2008 at,8:30 a.m. EDT to discuss the ... Chief Executive Officer of the Company, will host,the call. ... in a,press release to be issued prior to the ...
Cached Biology Technology:Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference 2Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference 3Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008 2Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008 3Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008 4Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT 2
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ... team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ... – with the clinical data to back it up," ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... for our brains and memory. But what is it about ... our memory sharper? Medical researchers at the University of ... in the peer-reviewed journal Applied Physiology, Nutrition, and Metabolism ... lab models fed a high-DHA diet had 30 per cent ...
... introduced to the U.S. for sale through plant nurseries, ... Although legislation restricts the introduction of certain species, the ... restricted list are haphazard and out of date. ... risk analysis, researchers at the University of Georgia Odum ...
... lines for American Idol demonstrate anything, it,s that people like ... audience, the better. Now researchers at Tel Aviv University have ... indigenous to Africa and the Middle East. According ... TAU,s Department of Zoology, hyrax vocalizations or "songs" go a ...
Cached Biology News:Screening horticultural imports: New models assess plant risk through better analysis 2Screening horticultural imports: New models assess plant risk through better analysis 3Looking for the next American hyrax? 2Looking for the next American hyrax? 3Looking for the next American hyrax? 4
... Custom design, The Bioactive peptides are ... display a biological behaviour or activity which ... for pharmaceutical, diagnostic, chemical and agro-food applications. ... obtain modified peptides with superior properties for ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
... with forced convection Temperature range 5 C ... C / 212 F Patented APT.line preheating ... DS controller Timer 0 to 24 h ... a tenth of a degree Independent adjustable ...
... your microarray data using Asuragens bioinformatics ... need from consultation to extensive data ... date methods. Utilize our expertise in ... Service or from your own microarray ...
Biology Products: